<DOC>
	<DOCNO>NCT02770274</DOCNO>
	<brief_summary>To compare safety effectiveness dual anti-platelet therapy cilostazol 100 mg twice daily aspirin 100 mg daily versus monotherapy aspirin 100 mg daily patient undergoing peripheral angioplasty stenting management peripheral arterial disease .</brief_summary>
	<brief_title>Cilostazol Following Peripheral Endovascular Procedures</brief_title>
	<detailed_description>This multi-center , randomize , single-blinded , phase III , control trial investigating safety effectiveness dual antiplatelet therapy cilostazol 100 mg twice daily aspirin 100 mg daily versus monotherapy aspirin 100 mg daily patient undergoing peripheral , infrainguinal angioplasty stenting management peripheral arterial disease ( intermittent claudication critical limb ischemia ) . The study include total 200 patient randomize 1:1 basis receive either dual antiplatelet therapy 6 month cilostazol 100 mg daily aspirin 100 mg daily versus monotherapy aspirin 100 mg daily 12 month . The study 's primary endpoint composite major adverse cardiovascular event ( cardiovascular death , myocardial infarction , stroke , major amputation , target limb open surgical endovascular revascularization ) . Additional therapy clopidogrel 75mg daily add either group one month case stent placement . Secondary endpoint include quality life assessment use dedicated questionnaire , drug- procedure-related complication rate , target-limb revascularization rate , clinical improvement ( ABI Rutherford-Becker classification change ) . Clinical follow perform 1 , 6 12 month include physical examination , ABI measurement , Rutherford-Becker classification . Maximum follow period 2 year index procedure .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<criteria>Scheduled infrainguinal ( femoropopliteal infrapopliteal ) angioplasty and/or stenting . Surgical endovascular treatment Inflow iliac artery significant stenosis deem necessary . Symptomatic severe intermittent claudication ( RutherfordBecker 3 ) critical limb ischemia ( RutherfordBecker 46 ) . Informed consent sign Any contraindication aspirin cilostazol intake No pedal arch outflow Sole iliac artery treatment Standard contraindication angioplasty Acute subacute limb ischemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>